We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A previous Avalere analysis found plans were increasingly placing generic drugs in non-generic tiers that require higher patient cost-sharing. Read More
The agency said it’s unnecessary to change the proper names of biological products that have already received licensing or approval and that lack an FDA-designated suffix. Read More
The FDA on Tuesday issued five guidance documents—including one final guidance—that the agency hopes will help sponsors get a handle on increasingly complex cancer trials. Read More
A federal court ordered Dallas, Texas-based drug compounder Guardian Pharmacy Services to suspend compounding activities, based on violations flagged by the FDA. Read More
National Cancer Institute Director Norman “Ned” Sharpless will serve as acting commissioner of the FDA following Scott Gottlieb’s departure next month. Read More
A False Claims Act suit claiming pharmacies Walgreens purchased in 2012 overcharged Medicaid for generic drugs must proceed, according to an Oklahoma federal judge. Read More